No 13F manager has reported this stock in the last 8 quarters.
None.
None.
No insider has filed a notice of proposed sale (Form 144) for BlossomHill Therapeutics, Inc. in the last 12 months.
There are not yet two fiscal years of reported share counts for BlossomHill Therapeutics, Inc..
No 13F manager reports holding BLSM.
| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
SB
Fidelity Select Portfolios
|
$6.36M | 347.4K | 1.87% | 0.10% | August 31, 2026 |
|
MS
Columbia Funds Series Trust I
|
$1.35M | 73.7K | 0.40% | 0.12% | August 31, 2026 |
7 more funds behind a free account
See every fund holding BlossomHill Therapeutics, Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
CJ
Cui Jingrong Jean
Insider
|
4.0M | 21.41% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company21.410%
|
||||||
|
LY
Li Yishan
Insider
|
4.0M | 21.41% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company21.410%
|
||||||
14 more holders behind a free account
See every insider and 5%+ holder of BlossomHill Therapeutics, Inc..
Sign up freeLoading...